{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:39:25Z","timestamp":1787236765523,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"DOI":"10.1007\/s00210-026-05831-7","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T01:16:13Z","timestamp":1787188573000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sulforaphane mitigates behavioral deficits in experimental chronic kidney disease through regulation of Nrf2\/NLRP3 inflammasome"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0459-104X","authenticated-orcid":false,"given":"Hend S.","family":"Zakaria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed T.","family":"Ghoneim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa A.","family":"Ghareeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliaa A.","family":"Masoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherouk S.","family":"Shams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"issue":"2","key":"5831_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1515\/prilozi-2017-0020","volume":"38","author":"HK Aggarwal","year":"2017","unstructured":"Aggarwal HK, Jain D, Dabas G, Yadav RK (2017) Prevalence of depression, anxiety and insomnia in chronic kidney disease patients and their co-relation with the demographic variables. Prilozi 38(2):35\u201344","journal-title":"Prilozi"},{"issue":"1","key":"5831_CR2","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1258\/ebm.2010.010163","volume":"236","author":"BH Ali","year":"2011","unstructured":"Ali BH, Ziada A, Al Husseni I, Beegam S, Nemmar A (2011) Motor and behavioral changes in rats with adenine-induced chronic renal failure: influence of acacia gum treatment. Exp Biol Med (Maywood) 236(1):107\u2013112","journal-title":"Exp Biol Med (Maywood)"},{"key":"5831_CR3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.biopha.2018.09.061","volume":"108","author":"BH Ali","year":"2018","unstructured":"Ali BH, Al Za\u2019abi M, Adham SA, Al Suleimani Y, Karaca T, Manoj P, Al Kalbani J, Yasin J, Nemmar A (2018) The effect of sildenafil on rats with adenine\u2014induced chronic kidney disease. Biomed Pharmacother 108:391\u2013402","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"5831_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.33594\/000000003","volume":"52","author":"BH Ali","year":"2019","unstructured":"Ali BH, Al Salam S, Al Suleimani Y, Al Za\u2019abi M, Abdelrahman AM, Ashique M, Manoj P, SA Adham, C Hartmann, Schupp N, Nemmar A (2019) Effects of the SGLT-2 inhibitor canagliflozin on adenine-induced chronic kidney disease in rats. Cell Physiol Biochem. 52(1):27\u201339","journal-title":"Cell Physiol Biochem."},{"issue":"7","key":"5831_CR5","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.drudis.2020.05.001","volume":"25","author":"S Bhatt","year":"2020","unstructured":"Bhatt S, Nagappa AN, Patil CR (2020) Role of oxidative stress in depression. Drug Discov Today 25(7):1270\u20131276","journal-title":"Drug Discov Today"},{"key":"5831_CR6","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1590\/1516-4446-2013-1139","volume":"35","author":"AC Campos","year":"2013","unstructured":"Campos AC, Foga\u00e7a MV, Aguiar DC, Guimaraes FS (2013) Animal models of anxiety disorders and stress. Braz J Psychiatry 35:S101\u2013S111","journal-title":"Braz J Psychiatry"},{"issue":"1","key":"5831_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s11658-023-00462-9","volume":"28","author":"Y Chen","year":"2023","unstructured":"Chen Y, Ye X, Escames G, Lei W, Zhang X, Li M, Jing T, Yao Y, Qiu Z, Wang Z, Acu\u00f1a-Castroviejo D (2023) The NLRP3 inflammasome: contributions to inflammation-related diseases. Cell Mol Biol Lett 28(1):51","journal-title":"Cell Mol Biol Lett"},{"key":"5831_CR8","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.jpsychires.2025.03.023","volume":"184","author":"H Chen","year":"2025","unstructured":"Chen H, Lu J, Zou T, Teng Z, Qin Y, Wu R, Yan Y, Fu K, Jiang W, Ju Y, Zhu R (2025) Effects of sulforaphane on negative symptoms and cognitive impairments in chronic schizophrenia patients: a randomized double-blind trial. J Psychiatr Res 184:464\u2013472","journal-title":"J Psychiatr Res"},{"key":"5831_CR9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.brainres.2010.09.049","volume":"1363","author":"ES Chung","year":"2010","unstructured":"Chung ES, Chung YC, Bok E, Baik HH, Park ES, Park JY, Yoon SH, Jin BK (2010) Fluoxetine prevents LPS-induced degeneration of nigral dopaminergic neurons by inhibiting microglia-mediated oxidative stress. Brain Res 1363:143\u2013150","journal-title":"Brain Res"},{"issue":"2","key":"5831_CR10","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3390\/antiox12020470","volume":"12","author":"AS Correia","year":"2023","unstructured":"Correia AS, Cardoso A, Vale N (2023) Oxidative stress in depression: the link with the stress response, neuroinflammation, serotonin, neurogenesis and synaptic plasticity. Antioxidants (Basel) 12(2):470","journal-title":"Antioxidants (Basel)"},{"issue":"9","key":"5831_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyw037","volume":"19","author":"RH Du","year":"2016","unstructured":"Du RH, Tan J, Sun XY, Lu M, Ding JH, Hu G (2016) Fluoxetine inhibits NLRP3 inflammasome activation: implication in depression. Int J Neuropsychopharmacol 19(9):pyw037","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1","key":"5831_CR12","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","volume":"82","author":"GL Ellman","year":"1959","unstructured":"Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82(1):70\u201377","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"5831_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1053\/j.ajkd.2011.12.033","volume":"60","author":"MJ Fischer","year":"2012","unstructured":"Fischer MJ, Xie D, Jordan N, Kop WJ, Krousel-Wood M, Tamura MK, Kusek JW, Ford V, Rosen LK, Strauss L, Teal VL (2012) Factors associated with depressive symptoms and use of antidepressant medications among participants in the Chronic Renal Insufficiency Cohort (CRIC) and Hispanic-CRIC studies. Am J Kidney Dis 60(1):27\u201338","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"5831_CR14","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1007\/s12035-022-03201-x","volume":"60","author":"J Folbergrov\u00e1","year":"2023","unstructured":"Folbergrov\u00e1 J, Je\u0161ina P, Ot\u00e1hal J (2023) Protective effect of sulforaphane on oxidative stress and mitochondrial dysfunction associated with status epilepticus in immature rats. Mol Neurobiol 60(4):2024\u20132035","journal-title":"Mol Neurobiol"},{"issue":"8","key":"5831_CR15","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/pcn.13276","volume":"75","author":"F Ghazizadeh\u2010Hashemi","year":"2021","unstructured":"Ghazizadeh\u2010Hashemi F, Bagheri S, Ashraf\u2010Ganjouei A, Moradi K, Shahmansouri N, Mehrpooya M, Noorbala AA, Akhondzadeh S (2021) Efficacy and safety of sulforaphane for treatment of mild to moderate depression in patients with history of cardiac interventions: a randomized, double-blind, placebo-controlled clinical trial. Psychiatry Clin Neurosci 75(8):250\u2013255","journal-title":"Psychiatry Clin Neurosci"},{"issue":"2","key":"5831_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19020562","volume":"19","author":"P Hennig","year":"2018","unstructured":"Hennig P, Garstkiewicz M, Grossi S, Di Filippo M, French LE, Beer HD (2018) The crosstalk between Nrf2 and inflammasomes. Int J Mol Sci 19(2):562","journal-title":"Int J Mol Sci"},{"key":"5831_CR17","doi-asserted-by":"crossref","unstructured":"Huang J, Chen A, Jin H, Liu F, Hei G, Teng Z, Xiao J, Wu R, Zhao J, Davis JM, Shao P, Smith RC (2025) Efficacy and safety of sulforaphane added to antipsychotics for the treatment of negative symptoms of schizophrenia: a randomized controlled trial. J Clin Psychiatry 86(1):24m15272","DOI":"10.4088\/JCP.24m15272"},{"issue":"6","key":"5831_CR18","first-page":"AF01","volume":"11","author":"S Jayakumar","year":"2017","unstructured":"Jayakumar S, Raghunath G, Ilango S, Vijayakumar J, Vijayaraghavan R (2017) Effect of fluoxetine on the hippocampus of Wistar albino rats in cold restraint stress model. J Clin Diagn Res 11(6):AF01\u2013AF06","journal-title":"J Clin Diagn Res"},{"issue":"12","key":"5831_CR19","doi-asserted-by":"publisher","first-page":"5839","DOI":"10.1017\/S0033291722003099","volume":"53","author":"S Jayakumar","year":"2023","unstructured":"Jayakumar S, Jennings S, Halvorsrud K, Clesse C, Yaqoob MM, Carvalho LA, Bhui K (2023) A systematic review and meta-analysis of the evidence on inflammation in depressive illness and symptoms in chronic and end-stage kidney disease. Psychol Med 53(12):5839\u20135851","journal-title":"Psychol Med"},{"key":"5831_CR20","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jneuroim.2017.10.016","volume":"313","author":"SW Jeon","year":"2017","unstructured":"Jeon SW, Kim YK (2017) Inflammation-induced depression: its pathophysiology and therapeutic implications. J Neuroimmunol 313:92\u201398","journal-title":"J Neuroimmunol"},{"issue":"9","key":"5831_CR21","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1002\/2211-5463.13670","volume":"13","author":"H Jin","year":"2023","unstructured":"Jin H, Xu G, Lu Y, Niu C, Zhang X, Kan T, Cao J, Yang X, Cheng Q, Zhang J, Dong J (2023) Fluoxetine partially alleviates inflammation in the kidney of socially stressed male C57 BL\/6 mice. FEBS Open Bio 13(9):1723\u20131736","journal-title":"FEBS Open Bio"},{"issue":"7","key":"5831_CR22","first-page":"2137","volume":"10","author":"W Jing","year":"2018","unstructured":"Jing W, Jabbari B, Vaziri ND (2018) Uremia induces upregulation of cerebral tissue oxidative\/inflammatory cascade, down-regulation of Nrf2 pathway and disruption of blood brain barrier. Am J Transl Res 10(7):2137\u20132147","journal-title":"Am J Transl Res"},{"issue":"3","key":"5831_CR23","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3904\/kjim.2021.492","volume":"37","author":"DS Kim","year":"2022","unstructured":"Kim DS, Kim SW, Gil HW (2022) Emotional and cognitive changes in chronic kidney disease. Korean J Intern Med 37(3):489\u2013500","journal-title":"Korean J Intern Med"},{"key":"5831_CR24","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.molimm.2021.10.014","volume":"140","author":"C Kiser","year":"2021","unstructured":"Kiser C, Gonul CP, Olcum M, Genc S (2021) Inhibitory effects of sulforaphane on NLRP3 inflammasome activation. Mol Immunol 140:175\u2013185","journal-title":"Mol Immunol"},{"issue":"5","key":"5831_CR25","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1007\/s43440-022-00420-w","volume":"74","author":"J Kryst","year":"2022","unstructured":"Kryst J, Majcher-Ma\u015blanka I, Chocyk A (2022) Effects of chronic fluoxetine treatment on anxiety- and depressive-like behaviors in adolescent rodents - systematic review and meta-analysis. Pharmacol Rep 74(5):920\u2013946","journal-title":"Pharmacol Rep"},{"key":"5831_CR26","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.3389\/fimmu.2019.01696","volume":"10","author":"CH Lee","year":"2019","unstructured":"Lee CH, Giuliani F (2019) The role of \u0131nflammation in depression and fatigue. Front Immunol 10:1696","journal-title":"Front Immunol"},{"issue":"4","key":"5831_CR27","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method. Methods 25(4):402\u2013408","journal-title":"Methods"},{"key":"5831_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.lfs.2016.07.020","volume":"161","author":"MK Mazumder","year":"2016","unstructured":"Mazumder MK, Giri A, Kumar S, Borah A (2016) A highly reproducible mice model of chronic kidney disease: evidences of behavioural abnormalities and blood-brain barrier disruption. Life Sci 161:27\u201336","journal-title":"Life Sci"},{"issue":"12","key":"5831_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14124120","volume":"14","author":"D Moldovan","year":"2025","unstructured":"Moldovan D, Kacso I, Avram L, Crisan D, Condor A, Bondor C, Rusu C, Potra A, Tirinescu D, Ticala M, Maslyennikov Y, B\u0103rar A, Urs A, Donca V (2025) Mental health and kidneys: the interplay between cognitive decline, depression, and kidney dysfunction in hospitalized older adults. J Clin Med 14(12):4120","journal-title":"J Clin Med"},{"key":"5831_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121664","volume":"322","author":"EB Monteiro","year":"2023","unstructured":"Monteiro EB, Ajackson M, Stockler-Pinto MB, Guebre-Egziabher F, Daleprane JB, Soulage CO (2023) Sulforaphane exhibits potent renoprotective effects in preclinical models of kidney diseases: a systematic review and meta-analysis. Life Sci 322:121664","journal-title":"Life Sci"},{"issue":"3","key":"5831_CR31","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jpsychires.2011.11.009","volume":"46","author":"M Moretti","year":"2012","unstructured":"Moretti M, Colla A, de Oliveira BG, dos Santos DB, Budni J, de Freitas AE, Farina M, Rodrigues AL (2012) Ascorbic acid treatment, similarly to fluoxetine, reverses depressive-like behavior and brain oxidative damage induced by chronic unpredictable stress. J Psychiatr Res 46(3):331\u2013340","journal-title":"J Psychiatr Res"},{"key":"5831_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-023-02585-4","author":"MM Nageeb","year":"2023","unstructured":"Nageeb MM, Talaat A, Reda SM, Elsammak GA (2023) Infliximab abrogates adenine-induced chronic kidney disease via modulation of the MAPK\/JNK\/ASK signaling pathway in rats. Naunyn Schmiedebergs Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-023-02585-4","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"5831_CR33","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/ki.2013.77","volume":"84","author":"S Palmer","year":"2013","unstructured":"Palmer S, Vecchio M, Craig JC, Tonelli M, Johnson DW, Nicolucci A, Pellegrini F, Saglimbene V, Logroscino G, Fishbane S, Strippoli GF (2013) Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies. Kidney Int 84(1):179\u201391","journal-title":"Kidney Int"},{"key":"5831_CR34","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.bbi.2014.04.007","volume":"41","author":"Y Pan","year":"2014","unstructured":"Pan Y, Chen XY, Zhang QY, Kong LD (2014) Microglial NLRP3 inflammasome activation mediates IL-1\u03b2-related inflammation in prefrontal cortex of depressive rats. Brain Behav Immun 41:90\u2013100","journal-title":"Brain Behav Immun"},{"issue":"6","key":"5831_CR35","doi-asserted-by":"publisher","first-page":"762","DOI":"10.3390\/ph17060762","volume":"17","author":"P Pa\u0144czyszyn-Trzewik","year":"2024","unstructured":"Pa\u0144czyszyn-Trzewik P, Stachowicz K, Misztak P, Nowak G, Sowa-Ku\u0107ma M (2024) Repeated sulforaphane treatment reverses depressivelike behavior and exerts antioxidant effects in the olfactory bulbectomy model in mice. Pharmaceuticals (Basel) 17(6):762","journal-title":"Pharmaceuticals (Basel)"},{"issue":"4","key":"5831_CR36","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","volume":"47","author":"RD Porsolt","year":"1978","unstructured":"Porsolt RD, Anton G, Blavet N, Jalfre M (1978) Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 47(4):379\u2013391","journal-title":"Eur J Pharmacol"},{"key":"5831_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2025.116797","volume":"233","author":"Q Qi","year":"2025","unstructured":"Qi Q, Wu N, Luo Z, Zhang Z, Liu S, Zhang J, Deng R, Luo Z (2025) Sulforaphane: an emerging star in neuroprotection and neurological disease prevention. Biochem Pharmacol 233:116797","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"5831_CR38","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1017\/S0033291721004943","volume":"52","author":"AJ Rush","year":"2022","unstructured":"Rush AJ, Sackeim HA, Conway CR, Bunker MT, Hollon SD, Demyttenaere K, Young AH, Aaronson ST, Dibu\u00e9 M, Thase ME, McAllister-Williams RH (2022) Clinical research challenges posed by difficult-to-treat depression. Psychol Med 52(3):419\u2013432","journal-title":"Psychol Med"},{"issue":"19","key":"5831_CR39","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.1958","volume":"6","author":"T Serchov","year":"2016","unstructured":"Serchov T, van Calker D, Biber K (2016) Sucrose preference test to measure anhedonic behaviour in mice. Bio-Protoc 6(19):e1958","journal-title":"Bio-Protoc"},{"key":"5831_CR40","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.etap.2018.12.008","volume":"66","author":"NM Shawky","year":"2019","unstructured":"Shawky NM, Shehatou GS, Suddek GM, Gameil NM (2019) Comparison of the effects of sulforaphane and pioglitazone on insulin resistance and associated dyslipidemia, hepatosteatosis, and endothelial dysfunction in fructose-fed rats. Environ Toxicol Pharmacol 66:43\u201354","journal-title":"Environ Toxicol Pharmacol"},{"issue":"2","key":"5831_CR41","first-page":"61","volume":"4","author":"MDS Shephard","year":"1983","unstructured":"Shephard MDS, Mezzachi RD (1983) Clin Biochem Rev 4(2):61\u201367","journal-title":"Clin Biochem Rev"},{"issue":"2","key":"5831_CR42","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/0003-9861(59)90259-0","volume":"80","author":"AL Tappel","year":"1959","unstructured":"Tappel AL, Zalkin H (1959) Inhibition of lipid peroxidation in mitochondria by vitamin E. Arch Biochem Biophys 80(2):333\u2013336","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"5831_CR43","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/hdi.12200","volume":"19","author":"M Taraz","year":"2015","unstructured":"Taraz M, Taraz S, Dashti-Khavidaki S (2015) Association between depression and inflammatory\/anti-inflammatory cytokines in chronic kidney disease and end-stage renal disease patients: A review of literature. Hemodialysis International. 19(1):11\u201322","journal-title":"Hemodialysis International."},{"key":"5831_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.865772","volume":"13","author":"B Tastan","year":"2022","unstructured":"Tastan B, Arioz BI, Genc S (2022) Targeting NLRP3 inflammasome with Nrf2 inducers in central nervous system disorders. Front Immunol 13:865772","journal-title":"Front Immunol"},{"key":"5831_CR45","volume-title":"Textbook of clinical chemistry","author":"NW Tietz","year":"1986","unstructured":"Tietz NW (1986) Textbook of clinical chemistry. WB saunders, philadelphia"},{"key":"5831_CR46","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.imlet.2021.03.004","volume":"233","author":"KU Tufekci","year":"2021","unstructured":"Tufekci KU, Ercan I, Isci KB, Olcum M, Tastan B, Gonul CP, Genc K, Genc S (2021) Sulforaphane inhibits NLRP3 inflammasome activation in microglia through Nrf2-mediated miRNA alteration. Immunol Lett 233:20\u201330","journal-title":"Immunol Lett"},{"issue":"26","key":"5831_CR47","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000020981","volume":"99","author":"C Wu","year":"2020","unstructured":"Wu C, Chen X, Lai J, Xu Y, Hu S (2020) The efficacy and safety of sulforaphane as an adjuvant in the treatment of bipolar depressive disorder: study protocol for a randomized, double-blinded, placebo-controlled, parallel-group clinical trial. Medicine (Baltimore) 99(26):e20981","journal-title":"Medicine (Baltimore)"},{"key":"5831_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106625","volume":"187","author":"CY Xia","year":"2023","unstructured":"Xia CY, Guo YX, Lian WW, Yan Y, Ma BZ, Cheng YC, Xu JK, He J, Zhang WK (2023) The NLRP3 inflammasome in depression: potential mechanisms and therapies. Pharmacol Res 187:106625","journal-title":"Pharmacol Res"},{"issue":"1","key":"5831_CR49","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2024.2336128","volume":"46","author":"Q Yang","year":"2024","unstructured":"Yang Q, Su S, Luo N, Cao G (2024) Adenine-induced animal model of chronic kidney disease: current applications and future perspectives. Ren Fail 46(1):2336128","journal-title":"Ren Fail"},{"issue":"5","key":"5831_CR50","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s00406-023-01679-7","volume":"274","author":"J Zeng","year":"2024","unstructured":"Zeng J, Zhang W, Lu X et al (2024) The association of SOD and hsCRP with the efficacy of sulforaphane in schizophrenia patients with residual negative symptoms. Eur Arch Psychiatry Clin Neurosci 274(5):1083\u20131092","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"8","key":"5831_CR51","doi-asserted-by":"publisher","first-page":"pyv006","DOI":"10.1093\/ijnp\/pyv006","volume":"18","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Liu L, Liu YZ, Shen XL, Wu TY, Zhang T, Wang W, Wang YX, Jiang CL (2015) NLRP3 inflammasome mediates chronic mild stress-induced depression in mice via neuroinflammation. Int J Neuropsychopharmacol 18(8):pyv006","journal-title":"Int J Neuropsychopharmacol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05831-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05831-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05831-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:07:07Z","timestamp":1787234827000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05831-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":51,"alternative-id":["5831"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05831-7","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"assertion":[{"value":"26 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The investigation complies with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication no. 85\u201323, revised 1996). The Ethical dria, Egypt, approved our research protocol (IRB NO: 00012098-FWA NO: 00018699).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}